Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity
NCT ID: NCT06266598
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
52 participants
INTERVENTIONAL
2019-11-17
2021-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sestrin-2 Levels and Insulin Resistance
NCT06779721
Effect of Food Insulin Index on Metabolic Parameters in Obese Adolescents
NCT03387293
The Effects of Early vs. Delayed Time-Restricted Eating on Metabolic Syndrome Parameters
NCT07096505
Prevent and Reverse Obesity in Children, Adolescents and Young Adults
NCT07035704
Gut Microbiota in Obesity and Diabetes
NCT02180191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
obesity
Children with obesity were recommended to have a diet appropriate for their age and gender and exercise at least 3 days a week for at least 60 minutes each time.
All obese children under the age of 14 were started on metformin treatment at 1000 mg (500 mgx2) per day, and children over this age were started on metformin treatment at the adult dose of 2000 mg (1000 mgx2) per day.
Metformin
Only obese children with insulin resistance were treated with metformin.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metformin
Only obese children with insulin resistance were treated with metformin.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having insulin resistance
* Having a family history of Type 2 diabetes mellitus (T2DM)
Exclusion Criteria
* Having T1DM and T2DM
* History of drug use
9 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HÜMEYRA ACIKAN
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HÜMEYRA ACIKAN
Research asistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University
Kayseri, Melikgazi, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EU-TF-HA-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.